Healthcare -
Biotechnology - NASDAQ - US
$ 0.54
-5.92 %
$ 18.8 M
Market Cap
-0.57
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Ocean Biomedical, Inc.
| Net Income | -114 M |
| Depreciation & Amortization | 1.52 M |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 1.2 M |
| Change in Working Capital | 1.18 M |
| Others | 103 M |
| Free Cash Flow | -9.43 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (114.5) | (1.0) | (62.3) | (1.7) | (0.2) |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 1.2 | 0 | 56.5 | 0 | 0 |
| Other Operating Activities | 102.7 | (1.5) | 2.45 K | 0 | 0 |
| Change in Working Capital | 1.2 | 1.7 | 4.7 | 1.6 | 0.2 |
| Cash From Operations | (9.4) | (0.7) | (1.1) | 64 K | 0 |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | 0 | 3 | 0 | 0 | 0 |
| Other Items | 0 | (2.1) | (107.1) | 0 | 0 |
| Cash From Investing Activities | 0 | (2.1) | (107.1) | 0 | 0 |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | (64.3) | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 6.8 | 2.1 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 52.1 | 0 | 96 K | 64 K | 0 |
| Cash From Financing Activities | 10.4 | 2.1 | 1.1 | 64 K | 0 |
| CHANGE IN CASH | |||||
| Net Change In Cash | 1.0 | (0.7) | 60 K | 0 | 0 |
| FREE CASH FLOW | |||||
| Free Cash Flow | (9.4) | (0.7) | (1.1) | 64 K | 0 |